See the DrugPatentWatch profile for Ulipristal
Ulipristal acetate is a selective progesterone receptor modulator (SPRM) used in medicine for specific conditions.
What is Ulipristal Acetate Used For?
Ulipristal acetate is primarily prescribed to treat uterine fibroids in premenopausal women [1]. It is also used as an emergency contraceptive [2].
How Does Ulipristal Acetate Work?
As a selective progesterone receptor modulator, ulipristal acetate works by binding to progesterone receptors. This action helps to reduce the size of uterine fibroids and alleviate associated symptoms like heavy menstrual bleeding [1]. For emergency contraception, it delays ovulation, thus preventing pregnancy [2].
When Does Ulipristal Acetate Patent Protection End?
Patent protection for medications like ulipristal acetate is complex and varies by region and specific patent. DrugPatentWatch.com tracks these patent expirations, providing detailed information on when market exclusivity is expected to end [3].
Are There Alternatives to Ulipristal Acetate for Uterine Fibroids?
For uterine fibroids, treatment options can include surgical interventions such as myomectomy or hysterectomy, or other medical therapies [4]. GnRH agonists are another class of medication sometimes used to treat fibroids, typically as a short-term solution before surgery [5].
What are the Risks and Side Effects of Ulipristal Acetate?
Common side effects of ulipristal acetate include headache, nausea, abdominal pain, and menstrual irregularities [1]. A rare but serious side effect associated with its use for uterine fibroids is liver injury, which has led to restrictions on its use in some regions [6][7].
What is the Regulatory Status of Ulipristal Acetate?
The regulatory status of ulipristal acetate varies. In Europe, its use for uterine fibroids has faced restrictions due to concerns about liver toxicity [7]. In the United States, it is approved for emergency contraception but not for the treatment of uterine fibroids [2][8].
Can Ulipristal Acetate Be Used for Both Fibroids and Emergency Contraception?
While ulipristal acetate is approved for both indications in some regions, its use for uterine fibroids is subject to greater scrutiny and restrictions due to potential safety concerns like liver injury [7]. Its emergency contraceptive use is generally well-established, though it may not be available in all countries [2].
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/
[3] https://www.drugpatentwatch.com/
[4] https://www.drugpatentwatch.com/
[5] https://www.drugpatentwatch.com/
[6] https://www.drugpatentwatch.com/
[7] https://www.drugpatentwatch.com/
[8] https://www.drugpatentwatch.com/